Kelly James Patrick
Novavax, Inc. ยท EVP
Kelly James Patrick is listed in public filings as officer: EVP, CFO and Treasurer. This Kelly James Patrick insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Novavax, Inc. (NVAX). Investors use Kelly James Patrick's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --12.2k shares | Grant / ExerciseMar 7, 2026 | Disclosure amount unavailable12.2k shares | -- | -- | |
| $1.3M130.6k shares | Grant / ExerciseMar 7, 2026 | $58.9K5.9k shares | $9.98 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.2M124.3k shares | Grant / ExerciseMar 3, 2026 | $197.9K20.9k shares | $9.49 | -- | |
| --86.3k shares | Grant / ExerciseMar 3, 2026 | Disclosure amount unavailable43.2k shares | -- | -- | |
| $2.0M194k shares | Grant / ExerciseMar 2, 2026 | $2.0M194k shares | $10.11 | -- | |
| $1.8M194k shares | Grant / ExerciseMar 2, 2026 | $1.8M194k shares | $9.09 | -- | |
| --129.5k shares | Grant / ExerciseMar 2, 2026 | Disclosure amount unavailable129.5k shares | -- | -- | |
| $1.0M102k shares | Grant / ExerciseMar 1, 2026 | $287.6K28.4k shares | $10.14 | -- | |
| --58.7k shares | OtherMar 1, 2026 | Disclosure amount unavailable58.7k shares | -- | -- | |
| --130.3k shares | Grant / ExerciseMar 1, 2026 | Disclosure amount unavailable58.7k shares | -- | -- | |
| --12.2k shares | Grant / ExerciseMar 7, 2025 | Disclosure amount unavailable12.2k shares | -- | -- | |
| $578k69.3k shares | Grant / ExerciseMar 7, 2025 | $49.2K5.9k shares | $8.34 | -- | |
| $1.5M194.5k shares | Grant / ExerciseMar 3, 2025 | $1.5M194.5k shares | $7.87 | -- | |
| --129.5k shares | Grant / ExerciseMar 3, 2025 | Disclosure amount unavailable129.5k shares | -- | -- | |
| $524k62.9k shares | Grant / ExerciseMar 1, 2025 | $236.0K28.3k shares | $8.33 | -- | |
| --91.3k shares | Grant / ExerciseMar 1, 2025 | Disclosure amount unavailable58.7k shares | -- | -- | |
| --35k shares | Grant / ExerciseDec 31, 2024 | Disclosure amount unavailable35k shares | -- | -- | |
| $262k32.6k shares | Grant / ExerciseDec 31, 2024 | $135.9K16.9k shares | $8.04 | -- | |
| --2.4k shares | Grant / ExerciseAug 16, 2024 | Disclosure amount unavailable2.4k shares | -- | -- | |
| $203k15.7k shares | Grant / ExerciseAug 16, 2024 | $30.7K2.4k shares | $12.96 | -- | |
| $187k14.4k shares | Grant / ExerciseAug 16, 2024 | $15.8K1.2k shares | $12.96 | -- |